HK1000801A1 - Compounds having antitumor and antibacterial properties - Google Patents
Compounds having antitumor and antibacterial propertiesInfo
- Publication number
- HK1000801A1 HK1000801A1 HK97102378A HK97102378A HK1000801A1 HK 1000801 A1 HK1000801 A1 HK 1000801A1 HK 97102378 A HK97102378 A HK 97102378A HK 97102378 A HK97102378 A HK 97102378A HK 1000801 A1 HK1000801 A1 HK 1000801A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- antibacterial properties
- represent
- lower alkyl
- groups
- antitumor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
- C07D311/86—Oxygen atoms, e.g. xanthones
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ21878186 | 1986-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1000801A1 true HK1000801A1 (en) | 1998-05-01 |
Family
ID=19921928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK97102378A HK1000801A1 (en) | 1986-12-23 | 1997-12-10 | Compounds having antitumor and antibacterial properties |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0278176B1 (es) |
JP (1) | JP2672101B2 (es) |
AT (1) | ATE102616T1 (es) |
DE (1) | DE3789299T2 (es) |
ES (1) | ES2061518T3 (es) |
HK (1) | HK1000801A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USH1427H (en) * | 1988-04-06 | 1995-04-04 | Briet; Phillipe | Substituted flavonoid compounds, their salts, their manufacture and their use in combination with interleukin-2 |
US5116954A (en) * | 1988-04-06 | 1992-05-26 | Lipha, Lyonnaise Industrielle Pharmaceutique | Pharmaceutically useful flavonoic compounds containing at least one substituent on the benzopyranone ring moiety |
US5238954A (en) * | 1989-01-19 | 1993-08-24 | The Upjohn Company | Fluorinated flavone acetic acid |
US4996230A (en) * | 1990-02-16 | 1991-02-26 | Eli Lilly And Company | Leukotriene antagonists |
JP2554447B2 (ja) * | 1993-09-14 | 1996-11-13 | ナショナル・サイエンス・カウンシル | 新規キサントン化合物 |
ES2265948T3 (es) * | 1999-06-14 | 2007-03-01 | Cancer Research Technology Limited | Terapia para el cancer. |
JP2001247459A (ja) * | 2000-03-03 | 2001-09-11 | Oakland Uniservices Ltd | 癌の組み合わせ療法 |
JP2004505047A (ja) | 2000-07-28 | 2004-02-19 | キャンサー・リサーチ・テクノロジー・リミテッド | 複合治療による癌治療 |
KR20030018214A (ko) * | 2001-08-27 | 2003-03-06 | 한국생명공학연구원 | 혈관 신생 저해제용 잔테논계 유도체 및 그를 포함하는혈관 신생 저해 조성물 |
GB0121285D0 (en) | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
GB2386836B (en) | 2002-03-22 | 2006-07-26 | Cancer Res Ventures Ltd | Anti-cancer combinations |
GB2394658A (en) | 2002-11-01 | 2004-05-05 | Cancer Rec Tech Ltd | Oral anti-cancer composition |
WO2008048117A2 (en) * | 2006-10-17 | 2008-04-24 | Auckland Uniservices Limited | Synthesis of 5,6-dimethyl-9-oxo-9h-xanthen-4-yl- acetic acid (dmxaa) |
CN101195609B (zh) * | 2007-09-28 | 2011-04-20 | 武汉远大制药集团有限公司 | 5,6-二甲基呫吨酮-4-乙酸的制备方法及由此方法制备的衍生物和药物制剂 |
CN101914084B (zh) * | 2010-07-30 | 2012-10-17 | 中国人民解放军第二军医大学 | 双苯吡喃酮氮杂环衍生物及其制备方法与应用 |
CN102786509B (zh) * | 2011-05-16 | 2016-06-01 | 杭州民生药业有限公司 | 2-(5,6-二甲基呫吨酮-4-基)-乙酸的衍生物及其制备方法和用途 |
TWI730037B (zh) * | 2016-01-26 | 2021-06-11 | 日商富士軟片和光純藥股份有限公司 | 光硬化方法,及用於該光硬化方法之化合物和組成物 |
EP3535243B1 (en) | 2016-11-04 | 2021-12-15 | Auckland Uniservices Limited | Substituted 9h-xanthen-9-one, 9h-thioxanthen-9-one and acridin-9(10h)-one derivatives and related compounds csf-1r inhibitors for the treatment of cancer |
CN106977489B (zh) * | 2017-04-20 | 2019-05-31 | 清华大学 | 一种制备多取代占吨酮类衍生物的方法 |
-
1987
- 1987-12-22 ES ES87311274T patent/ES2061518T3/es not_active Expired - Lifetime
- 1987-12-22 DE DE3789299T patent/DE3789299T2/de not_active Expired - Lifetime
- 1987-12-22 JP JP62325109A patent/JP2672101B2/ja not_active Expired - Lifetime
- 1987-12-22 AT AT87311274T patent/ATE102616T1/de not_active IP Right Cessation
- 1987-12-22 EP EP87311274A patent/EP0278176B1/en not_active Expired - Lifetime
-
1997
- 1997-12-10 HK HK97102378A patent/HK1000801A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0278176B1 (en) | 1994-03-09 |
JP2672101B2 (ja) | 1997-11-05 |
EP0278176A3 (en) | 1990-03-28 |
EP0278176A2 (en) | 1988-08-17 |
JPS63295570A (ja) | 1988-12-01 |
ES2061518T3 (es) | 1994-12-16 |
ATE102616T1 (de) | 1994-03-15 |
DE3789299T2 (de) | 1994-08-04 |
DE3789299D1 (de) | 1994-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1000801A1 (en) | Compounds having antitumor and antibacterial properties | |
FI873609A (fi) | Kemiluminoivia akridiinijohdannaisia, niiden valmistus ja niiden käyttö luminesenssi-immunoanalyyseissä | |
PL313589A1 (en) | Hydroxyl derivatives of compounds of azetidinone type useful as hypocholesterolaemic agents | |
BR1100662A (pt) | Compostos farmacologicamente aceitáveis; uso de um composto; e processo para a preparação dos compostos | |
DE69032818D1 (de) | Chemilumineszente Lösung auf Basis von substituiertem Anthracen | |
DE50000192D1 (de) | Azofarbstoffe, deren Herstellung und deren Verwendung | |
DE59403757D1 (de) | Neue Chinolon- und Naphthyridoncarbonsäurederivate | |
FI900760A0 (fi) | Benzensulfonamider och foerfarande foer deras framstaellning. | |
DE3688950D1 (de) | Substituierte Chinolinderivate. | |
DE69416191D1 (de) | Spiropyran-Derivate mit photochromischen Eigenschaften | |
ATE27452T1 (de) | Substituierte o-phenylendiaminderivate. | |
DE58905079D1 (de) | Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung. | |
AU588065B2 (en) | Substituted diazaoxaspirodecanes, preparation thereof and use thereof as stabilizers for polymers | |
ES517995A0 (es) | Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias. | |
FI893460A (fi) | Anvaendning av substituerade 3,4-dihydro -2h-bensopyraner som laekemedel mot funktionsstoerningar vilka tilltaepper lungorna, och/eller stoerningar i de avledande urinroeren. | |
ATE99303T1 (de) | Substituierte 3-amino-chromane. | |
FR2375188A1 (fr) | Pour : nitro-amines utilisables comme composantes de diazotation | |
SE7713968L (sv) | Basiskt alkylerade ditiosalicylsyraamider, sett for framstellning derav samt anvendning derav som lekemedel | |
IT1197631B (it) | Composti antrachinonici,loro preparazione e loro impiego come coloranti | |
ES8402858A1 (es) | Procedimiento para preparar una mezcla decolorantes azoicos. | |
DK0433239T3 (da) | Anvendelse af naphthoxaziner | |
ATE119394T1 (de) | Verwendung von myricetin-3-0-beta-d-glucuronid als arzneimittel. | |
JPS5340021A (en) | Anthraquinone compound and its preparation and dyeing therewith | |
ATE18922T1 (de) | Texturiertes nylon-6 filament. | |
FR2126120A1 (en) | Water-insoluble monoazoic dyes - for hydrophobic fibres,esp polyesters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20071221 |